Every drug has many names. Whodini connects them.
The same drug can be a research code in a trial registry, a generic name in a scientific database, and a brand name in an FDA record. Whodini brings 20+ trusted sources together in one knowledge graph, so you can decode a candidate’s experience and find the companies worth sourcing from.
Free to use. No credit card or password required. Just enter your work email, get a code, and you’re in.
Trusted sources
Built on what the industry relies on.
Regulatory filings, registered clinical trials, prescribing information, and established scientific databases.
- Regulatory
- Drugs@FDA
- Orange Book
- Purple Book
- FDA Novel Drug Approvals
- CBER Biologics Approvals
- FDA regulatory designations
- NDC Directory
- openFDA
- Clinical trials
- ClinicalTrials.gov
- Labels and terminology
- DailyMed
- RxNorm
- MeSH
- NCI Thesaurus
- NCI Drug Dictionary
- MED-RT
- FDA UNII
- GSRS
- Science
- ChEMBL
- ChEBI
- IUPHAR/BPS Guide to Pharmacology
- Open Targets
Normalized, synthesized, verified
We do the data work. You do the recruiting.
As a drug moves from the lab to the clinic to the market, it picks up new names along the way: research codes, pipeline codes, generic names, brand names. The companies behind it get acquired, merged, and renamed too. Whodini uses AI to turn those scattered records across 20+ sources into a connected knowledge graph purpose-built for talent acquisition.
Normalize. Match brand names, active ingredients, and pipeline codes to the right drug and company at every stage, so every record points to the same thing.
Synthesize. Connect drugs to companies, indications, trials, and approvals, and summarize what matters for your search.
Verify. Check AI-assisted work against the source records, so what you see matches what’s on record.
Pharma intelligence graph
What Whodini knows about each drug and company.
The details that help you source smarter and screen faster.
Over 10,000 pharma companies
- Portfolio of approved and experimental drugs
- Therapeutic areas and scientific focus
- Financials and company size
- Public or private, and parent company
- History, including acquisitions, mergers, and FDA approvals
- Global headquarters and U.S. locations
- Active or inactive status
Over 15,000 drugs
- Approved and experimental drugs
- Pipeline codes, active ingredients, and brand names
- FDA approvals: dates, indications, and regulatory designations
- Clinical trials: phases, status, dates, conditions, and sponsors
- Therapeutic area, modality, drug class, molecular target, dosage form, and route
- Who developed and markets it
- Related drugs by target, modality, and therapeutic area
Always growing
Pharma never stands still. Neither does our data.
Put pharma intelligence to work.
Bring a drug, a company, a profile, or a question.
Get started freeFree to use. No credit card or password required. Just enter your work email, get a code, and you’re in.